Clinical trial authorisation framework in Europe - overview
DevelopmentDevelopment of new tools tools and procedures-- Harmonisation of processes and practices-- with the aim to set up best practices between MS and to propose changes or clarification of guidelines and legislation - Public meetings: Bonn April 2010, Paris 11 June 2010, Brussels 18 Nov 2010. • EU Commission’s updated guidances •
Tags:
Clinical, Framework, Procedures, Overview, Trail, Europe, Authorisation, And procedures, Clinical trial authorisation framework in europe overview
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
Guidelines, European, Agency, Medicine, Harmonised, European medicines agency, Ich harmonised
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Product, Management, Lifecycle, Product lifecycle management
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guidelines, Good, Practices, Clinical, Good clinical practice e6
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Product, Medicinal, Traditional, Herbal, Products1 traditional herbal medicinal products, Products1
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Good, Practices, Pharmaceutical, Manufacturing, Active, Ingredients, Good manufacturing practice for active, Good manufacturing practice for active pharmaceutical ingredients
Related documents
IS Standards, Guidelines and Procedures for Auditing and ...
obamawhitehouse.archives.govProcedures for Auditing and Control Professionals ... without the prior written authorisation of ISACA. Reproduction of all or portions of this publication is solely permitted for academic, internal and non-commercial use, and must include full attribution as follows: " 2009
European Medicines Agency pre-authorisation procedural ...
www.ema.europa.euauthorisation procedures and to reflect the implementation of the new European legislation. Revised topics will be marked by “New” or “Rev” upon publication. The EMA emphasises the importance of pre-submission meetings between applicants and the EMA/(Co-) Rapporteur. Pre-submission meetings (which should take place approximately 7 ...
SAFE TRANSPORTATION OF CHILDREN
www.acecqa.gov.auThe written authorisation given by a parent or other person named in the child’s enrolment record must now also state: • – e.g. a government department that provides an if the authorisation is for a regular outing, a description of when the child is to be taken on the regular outings • if the authorisation is for an excursion that is not a
Safe, Children, Transportation, Authorisation, Safe transportation of children
Fostering Services National Minimum Standards
assets.publishing.service.gov.ukFostering Services: National Minimum . Standards. Fostering Services NMS cover.indd 1 02/03/2011 16:39:55
Standards, National, Minimum, National minimum standards, National minimum
Statement of Cash Flows
www.aasb.gov.auAASB 107 6 STANDARD Cash equivalents are short-term, highly liquid investments that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value. Cash flows are inflows and outflows of cash and cash equivalents. Operating activities are the principal revenue-producing activities of the entity and other activities
Kindergarten Funding Guide
www.education.vic.gov.au6 | kindergarten funding guide The Kindergarten Funding Guide (the guide) is designed to assist service providers that: • provide kindergarten programs in Victoria • currently receive kindergarten funding from the Department of Education and Training (the Department) or wish to receive